Aligos Therapeutics, Inc.
ALGS
Revenue
311.00k
▼-295.00k▼-48.68%
3 Months ChangeAssets
150.70M
▲80.61M▲115.00%
3 Months ChangeLiabilities
34.25M
▼-64.81M▼-65.42%
3 Months ChangeFree Cash Flow
-22.39M
▼-1.45M▼-6.90%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Cost Of Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Revenue
Cost Of Revenue
No Data
Date | Revenue | Cost Of Revenue |
---|---|---|
No Data |
Net Profit/Loss
Net Profit/Loss
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Net Profit/Loss
Baseline
No Data
Date | Net Profit/Loss |
---|---|
No Data |
Assets/Liabilities
Assets
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Liabilities
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Assets
Liabilities
No Data
Date | Assets | Liabilities |
---|---|---|
No Data |
Cash Flows
Operating (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Investing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Financing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Free Cash Flow
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
No Data
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
No Data |
EPS
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
EPS (Diluted)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
EPS
EPS (Diluted)
No Data
Date | EPS | EPS (Diluted) |
---|---|---|
No Data |
Outstanding Shares
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Outstanding Shares
No Data
Date | Outstanding Shares |
---|---|
No Data |
Recent Quarterly and Annual Filings
2024-09-05
Form 8-K
ID: 0001193125-24-214188
2024-08-19
Form 8-K
ID: 0001193125-24-202813
2024-08-08
Form 8-K
ID: 0001193125-24-196966
2024-08-06
Form 10-Q
ID: 0000950170-24-091828
2024-08-06
Form 8-K
ID: 0001171843-24-004482
2024-06-28
Form 8-K
ID: 0001193125-24-172218
2024-05-31
Form 8-K
ID: 0001193125-24-151729
2024-05-22
Form 8-K
ID: 0001193125-24-144929
2024-05-15
Form 8-K
ID: 0001193125-24-139476
2024-05-07
Form 10-Q
ID: 0000950170-24-054497